首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Frontiers in oncology

缩写:FRONT ONCOL

ISSN:2234-943X

e-ISSN:2234-943X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引33690
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Zejun Lu,Xuanrong Zhang,Zhiqiang Jiang et al. Zejun Lu et al.
Adenoid Cystic Carcinoma (ACC) is characterized by its aggressive nature, high propensity for perineural invasion, and significant risk of distant metastasis, particularly to the lungs. Therapeutic options for locally advanced or metastatic...
Lucia Cavelier,Leonie Saft,Birgitta Sander et al. Lucia Cavelier et al.
Platelet-derived growth factor receptor beta (PDGFRB)-rearranged myeloid/lymphoid neoplasms (MLNs) are rare hematologic malignancies typically responsive to tyrosine kinase inhibitors (TKIs) such as imatinib. However, resistance-particularl...
Lingling Gu,Lanfang Zhang,Wenxuan Huang et al. Lingling Gu et al.
Objective: To summarize the clinical characteristics and imaging features of intrathyroid thymic carcinoma (ITTC), along with diagnostic and therapeutic approaches, to increase awareness of this rare disease. ...
Wen-Hui Wang,Hong-Bo Li,Zhong-Yuan Cui et al. Wen-Hui Wang et al.
Introduction: The purpose of this study was to explore the correlation between the difference of Her-2 protein expression level in Her-2 positive breast cancer and the efficacy of neoadjuvant chemotherapy, so as to determ...
Frontiers Production Office Frontiers Production Office
[This corrects the article DOI: 10.3389/fonc.2025.1671973.]. Keywords: cadonilimab; cytotoxic T-lymphocyte-a...
Yulu Zhou,Junjie Cao,Siqi Zhang et al. Yulu Zhou et al.
The global incidence of thyroid cancer has increased significantly, and patients with advanced, recurrent, or radioiodine-refractory disease face a severe shortage of effective treatment options. The RET proto-oncogene serves as a key drive...
Calogera Claudia Spagnolo,Rosaria M Ruggeri,Angela Alibrandi et al. Calogera Claudia Spagnolo et al.
Immune checkpoint inhibitors (ICIs) have radically changed the therapeutic landscape of several cancers. However, only a limited number of predictive factors are currently available in clinical practice to select patients for immunotherapy....
Marcela Winkler,Thomas Breitkreuz,Jürgen Brust et al. Marcela Winkler et al.
Introduction: Cancer patients commonly suffer from substantial side effects of oncological therapies. Therefore, the Oncology Working Group of the Competence Network for Integrative Medicine in Baden-Württemberg, Germany...
Haiyun Tao,Chun Xiong,Lanju Tan et al. Haiyun Tao et al.
Background: Acute radiation-induced dermatitis (ARD) remains the most prevalent adverse event associated with radiotherapy;however, effective management options remain limited.This study was designed to evaluate the effic...
Shu&#x;ang Shu,Shuping Weng,Jinchao Gu Shu&#x;ang Shu
Background: To analyze the global, regional, and national epidemiological trends of lip and oral cancer (LOC) diseases attributable to tobacco from 1990 to 2021, with an emphasis on health inequalities. ...